CPT code 17111 reports the destruction of 15 or more benign skin lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or other destructive methods. It is a commonly used dermatologic procedural code that standardizes billing for high-volume lesion destruction in outpatient and ambulatory settings. Nationally, accurate use of this code affects provider reimbursement, billing compliance, and aggregated utilization measures for dermatologic procedural care.

Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for CPT code 17111, typical sites of service, common billing considerations, and benchmarking perspectives across major payers. The publication outlines how the code is structured, factors that influence coding choices (such as lesion count and lesion type exclusions), and where this service fits within dermatology procedural lines.

This summary equips readers with the clinical and billing context needed to interpret benchmarks, review policy or coverage updates, and understand where CPT code 17111 applies in practice. Data not available in the input are noted where applicable in detailed sections.